Medtronic says it priced $17 billion in a 7-tranche offering of senior notes worth a collective $17 billion, to help fund its $43 billion acquisition of Covidien.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1tFIHQd
Cap comentari:
Publica un comentari a l'entrada